Paloma Partners Management CO Biogen Inc. Put Options Transaction History

Paloma Partners Management CO

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $556,475 - $669,850	2,500 New	2,500 $646,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $1.26 Million - $1.43 Million	4,900 New	4,900 $1.36 Million
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $416,651 - $459,268	1,900 Added 52.78%	5,500 $1.29 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $4.55 Million - $5.95 Million	-15,500 Reduced 81.15%	3,600 $1.27 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $5.9 Million - $7.03 Million	-22,900 Reduced 54.52%	19,100 $5.54 Million
Q1 2018 May 15, 2018	SELL	$260.13 - $367.91 $2.42 Million - $3.42 Million	-9,300 Reduced 18.13%	42,000 $11.5 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $215,348 - $241,206	700 Added 1.38%	51,300 $16.3 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $14.2 Million - $16.7 Million	50,600	50,600 $15.8 Million

1,024

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.